US FDA explains post-market study requirements for approved medicines
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued final guidance explaining how it is implementing its authority under the FDA Amendments Act of 2007 to require certain post-marketing studies and clinical trials for approved prescription drugs and biologics1,2.